Perspective Therapeutics, Inc.
AMEX:CATXMedical - Devices
+$0.02 today
- Market cap
- $94.20M
- Beta
- 1.73
- P/E (TTM)
- -0.0
- EPS (TTM)
- -$107.27
Volume 2.69M
Average 1.44M
CATX Intangible Assets
Identifiable non-physical assets such as patents, trademarks, licenses, and customer relationships.
Perspective Therapeutics, Inc.AMEX: CATX
Intangible Assets · Q1 FY2026 · quarter ended Mar 2026
Intangible assets falls 20.0% from a year ago
Intangible assets stood at $40M at the end of Q1 FY2026, down 20.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +674.8% a year.
Context
- Intangible assets amounted to 9.7% of total assets at the end of Q1 FY2026, down 5.4 pp from a year earlier.
- Intangible assets increased in 1 of the last 3 fiscal years.
What to watch
Whether intangible assets keeps falling in the next quarterly balance sheet after a -20.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Intangible Assets history
USD · from the balance sheet
- Latest · FY2025
- 40M USD
- Year-over-year change
- -20.0%
- 4-year CAGR
- +339.7%
| Period | Period end | Intangible Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 40M | -20.0% |
| FY2024 | 2024-12-31 | 50M | -0.7% |
| FY2023 | 2023-12-31 | 50.35M | +58451.2% |
| FY2022 | 2022-12-31 | 86K | -19.6% |
| FY2021 | 2022-06-30 | 107K | — |
Intangible Assets vs competitors
How CATX compares with its peers on the latest reported figures
- CATX's Mar 2026 intangible assets of $40M is the highest of the 5 companies compared; the peer median is $0.
- Intangible assets amounts to 9.7% of total assets for CATX, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $40M | -20.0% | +674.8% | 9.7% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CATX) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for CATX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jun 2022 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 60.35M | 20.99M | 9.24M | 61.58M | 30.63M |
| Short-term Investments | 0 | 22.76M | 0 | 165.34M | 114.11M |
| Net Receivables | 1.65M | 1.36M | 1.18M | 116K | 6K |
| Inventory | 1.07M | 1.41M | 0 | 0 | 0 |
| Other Current Assets | 535K | 6.69M | 5.35M | 4.13M | 3.65M |
| Total Current Assets | 63.6M | 53.22M | 16.84M | 231.16M | 148.39M |
| Property, Plant & Equipment (Net) | 2.62M | 2.06M | 6.32M | 59.54M | 78.1M |
| Goodwill | 0 | 0 | 24.06M | 0 | 0 |
| Intangible Assets | 107K | 86K | 50.35M | 50M | 40M |
| Long-term Investments | 0 | 150K | 133K | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 926K | (2.3M) | 182K | 405K | 486K |
| Total Non-current Assets | 3.65M | 2.3M | 81.05M | 109.94M | 118.58M |
| Total Assets | 67.25M | 58.09M | 97.89M | 341.1M | 266.97M |
| Account Payables | 847K | 1.54M | 6.91M | 10.34M | 20.51M |
| Short-term Debt | 0 | 0 | 49K | 52K | 623K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 1.4M | 26.6M |
| Other Current Liabilities | 259K | (406K) | 4.73M | 5.48M | 1.46M |
| Total Current Liabilities | 1.85M | 2.68M | 15.66M | 18.23M | 28.68M |
| Long-term Debt | 0 | 0 | 1.68M | 1.63M | 1.01M |
| Deferred Tax Liabilities | 0 | 0 | 4.59M | 2.5M | 1.7M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 26.6M | 0 |
| Other Non-current Liabilities | 624K | 75K | 4.59M | 55K | 28.56M |
| Total Non-current Liabilities | 1.02M | 331K | 7.05M | 32.2M | 31.26M |
| Total Liabilities | 2.86M | 3.45M | 22.71M | 50.43M | 59.94M |
| Common Stock | 142K | 142K | 282K | 70K | 74K |
| Retained Earnings | (95.17M) | (105.93M) | (152.44M) | (231.72M) | (334.84M) |
| Accumulated OCI | 0 | 0 | 0 | (51K) | 110K |
| Other Stockholders Equity | 0 | 160.43M | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 64.39M | 54.64M | 75.18M | 290.67M | 207.03M |
| Total Debt | 652K | 524K | 2.55M | 4.06M | 1.63M |
| Net Debt | (59.7M) | (20.99M) | (6.69M) | (57.52M) | (29M) |
Perspective Therapeutics, Inc.
AMEX:CATX
Intrinsic Alpha fair value
Locked
Current Price
$0.78
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.